Marina Baretti, MD, Johns Hopkins University School of Medicine, Baltimore, MD, discusses the emerging role of cancer vaccines in treating hepatocellular carcinoma. As more types of cancer vaccines are being developed, the data suggest their use lies in early treatment, with minimal residual disease. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.